The Case for Procurement Transparency
In times of public health emergencies, States and the public cannot rely on the goodwill of pharmaceutical companies to ensure equitable vaccine rollout.

In times of public health emergencies, States and the public cannot rely on the goodwill of pharmaceutical companies to ensure equitable vaccine rollout.
The Principles set forth a human rights-based solidarity approach to limit the harmful effects of serious health crises.
What can the New York City Marathon teach those hoping to increase global vaccine equity? Quite a lot, it turns out.
Research funding contracts can help to safeguard against inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines.
Tackling the question of how to address the needs for sharing scientific research is fundamental to any pandemic treaty discussion.
The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.